STAT5A and chronic myelogenous leukemia, BCR-ABL1 positive: Thus, a decoy STAT5 oligonucleotide was able to downregulate the expression of key STAT5 target genes and growth in the K562 model of BCR-ABL1-mediated CML by sequestering activated STAT5 proteins [93].